Sphingosine 1-phosphate receptor agonists attenuate relapsing-remitting experimental autoimmune encephalitis in SJL mice

被引:192
作者
Webb, M [1 ]
Tharn, CS [1 ]
Lin, FF [1 ]
Lariosa-Willingham, K [1 ]
Yu, NC [1 ]
Hale, J [1 ]
Mandala, S [1 ]
Chun, J [1 ]
Rao, TS [1 ]
机构
[1] Merck Res Labs, Mol Neurosci Lab, San Diego, CA 92121 USA
关键词
relapsing-remitting EAE; FTY720; lymphopoenia; gene expression;
D O I
10.1016/j.jneuroim.2004.04.015
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
FTY720 is a prodrug for FTY-phosphate, an agonist at four of the five known receptors for sphingosine-1-phosphate (S1P). We show that administration of either FTY720 or FTY-P to SJL mice with established relapsing-remitting experimental autoimmune encephalitis (EAE) results in a rapid and sustained improvement in their clinical status, and a reversal of changes in expression of mRNAs encoding some myelin proteins and inflammatory mediators. EAE produced by adoptively transferring lymph node cells from immunized mice to naive hosts is similarly ameliorated by FTY-P. Treatment with FTY-P is accompanied by a dose-responsive peripheral lymphopoenia. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:108 / 121
页数:14
相关论文
共 41 条
[1]   The immune modulator FTY720 targets sphingosine 1-phosphate receptors [J].
Brinkmann, V ;
Davis, MD ;
Heise, CE ;
Albert, R ;
Cottens, S ;
Hof, R ;
Bruns, C ;
Prieschl, E ;
Baumruker, T ;
Hiestand, P ;
Foster, CA ;
Zollinger, M ;
Lynch, KR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (24) :21453-21457
[2]   FTY720: a novel transplantation drug that modulates lymphocyte traffic rather than activation [J].
Brinkmann, V ;
Pinschewer, D ;
Chiba, K ;
Feng, LL .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2000, 21 (02) :49-52
[3]   FTY720 alters lymphocyte homing and protects allografts without inducing general immunosuppression [J].
Brinkmann, V ;
Chen, S ;
Feng, L ;
Pinschewer, D ;
Nikolova, Z ;
Hof, R .
TRANSPLANTATION PROCEEDINGS, 2001, 33 (1-2) :530-531
[4]   FTY720: Altered lymphocyte traffic results in allograft protection. [J].
Brinkmann, V ;
Pinschewer, DD ;
Feng, L ;
Chen, S .
TRANSPLANTATION, 2001, 72 (05) :764-769
[5]  
BROWN A, 1982, LAB INVEST, V46, P171
[6]  
Chiba K, 1996, TRANSPLANT P, V28, P1056
[7]  
Chiba K, 1998, J IMMUNOL, V160, P5037
[8]   Lysophospholipid receptors: Implications for neural signaling [J].
Chun, J .
CRITICAL REVIEWS IN NEUROBIOLOGY, 1999, 13 (02) :151-168
[9]   Immune cell regulation and cardiovascular effects of sphingosine 1-phosphate receptor agonists in rodents are mediated via distinct receptor subtypes [J].
Forrest, M ;
Sun, SY ;
Hajdu, R ;
Bergstrom, J ;
Card, D ;
Doherty, G ;
Hale, J ;
Keohane, C ;
Meyers, C ;
Milligan, J ;
Mills, S ;
Nomura, N ;
Rosen, H ;
Rosenbach, M ;
Shei, GJ ;
Singer, II ;
Tian, M ;
West, S ;
White, V ;
Xie, J ;
Proia, RL ;
Mandala, S .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 309 (02) :758-768
[10]   Amelioration of experimental autoimmune encephalomyelitis in lewis rats by FTY720 treatment [J].
Fujino, M ;
Funeshima, N ;
Kitazawa, Y ;
Kimura, H ;
Amemiya, H ;
Suzuki, S ;
Li, XK .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2003, 305 (01) :70-77